FDA green lights DermaSensor’s skin cancer detection device in the US
HQ Team January 18, 2024: The FDA has approved US-based DermaSensor Inc.’s handheld wireless skin cancer detection device that is powered by artificial.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team January 18, 2024: The FDA has approved US-based DermaSensor Inc.’s handheld wireless skin cancer detection device that is powered by artificial.
India's Dr. Reddy's Laboratories has divested "certain" non-core dermatology brands of the company to Eris Lifesciences for INR 2.7 billion.
HQ team Torrent Pharmaceuticals Limited announced it would buy Indian company Curatio Healthcare (I) Private Limited, for INR 2,500 crore ($305 million), according.